Pharmacovigilance Programme of India.

Simple item page
dc.contributor.authorKansal, Dinesh
dc.contributor.authorSharma, Aradhna
dc.contributor.authorSawaraj, Sushma
dc.date.accessioned2015-06-30T10:26:14Z
dc.date.available2015-06-30T10:26:14Z
dc.date.issued2014-01
dc.description.abstractAdverse drug reactions from medicinal products are one of the important public health issues. The Pharmacovigilance system is used to monitor the safety of authorized medicinal products and detect any change to their risk-benefit balance. It is characterized by its structures, processes and outcomes. To run an effective Pharmacovigilance system a protocol is required for reporting adverse reactions associated with drug use.en_US
dc.identifier.citationKansal Dinesh, Sharma Aradhna, Sawaraj Sushma. Pharmacovigilance Programme of India. Sub-Himalayan Journal of Health Research. 2014 Jan-June; 1(1): 45-48.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/158702
dc.language.isoenen_US
dc.subject.meshAdverse Drug Reaction Reporting Systems --organization & administration
dc.subject.meshAdverse Drug Reaction Reporting Systems --standards
dc.subject.meshAdverse Drug Reaction Reporting Systems --trends
dc.subject.meshAdverse Drug Reaction Reporting Systems --utilization
dc.subject.meshIndia
dc.subject.meshPharmacovigilance
dc.subject.meshPublic Health --organization & administration
dc.titlePharmacovigilance Programme of India.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
shjhr2014v1n1p45.pdf
Size:
4.48 MB
Format:
Adobe Portable Document Format
Description:
Continuous Medical Education (CME)/National Programme Awareness
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Sub-Himalayan Journal of Health Research